OPINION: Wellness companies weaponize the gaping holes in women’s clinical research

(Finn Rigby • The Student Life)

At the beginning of the fall semester, one of my close friends underwent a significant health scare that prompted her to visit several medical specialists. Each of these visits was more disappointing than the last — she consistently found her doctors making hasty generalizations about her condition in an attempt to categorize it as something they easily knew how to treat. Others simply dismissed her symptoms and told her to return if she found herself in unbearable pain. When her condition worsened and manifested into pain so severe that she had to go to the emergency room, she was merely presented with a massive bill, and in rare circumstances, treatment to temporarily lessen her symptoms — only for her pain to return several days later. I watched as she tirelessly researched her symptoms in a desperate attempt to break this costly cycle, hoping to find answers on the internet or in advertised remedies rather than the healthcare system that was supposed to serve her. 

Many women, including myself, know this trend all too well, whether from our friends, our family or our own experiences. Billions of dollars currently flow into health products marketed towards women; as a result, women’s healthcare has become an oversaturated industry which paradoxically remains severely under-researched. Whether a matter of neglect, oversight or carelessness, the patriarchal systems underpinning women’s healthcare create a severe research gap in female health — one that prompts many women to turn to marketed healthcare products in an attempt to receive adequate care. Major companies pushing their products know this pattern and weaponize it for profit rather than directing their resources toward closing the gap. Women in the United States constitute 80% of all health and wellness product customers — and, ironically, most studies supporting the development of these products center on experiments conducted on men. Until 1986, clinical trials largely left women out, often excluding them for convenience. Only in 1993 did the U.S. Congress require the inclusion of women in clinical research. 

Like major corporations, federal healthcare providers consistently play into similar market-oriented incentives. Delivering adequate care to patients has never been a priority in a system that has always been, and continues to be, entrenched in inequalities and designed to favor profits. Our nation has the resources needed to exponentially advance women’s healthcare, but corporations will never find such an incentive worthwhile if it risks undercutting consumer engagement. Without significant redirection of clinical research funding, private corporations with minimal government regulation will continue to put shareholder profit and market competition above the people they are supposed to serve. 

Consequently, the women’s health and wellness market is currently valued between $312 billion and $360 billion, with a compound annual growth rate of 8.4% — accounting for 35.5 to 45.6% of global women’s wellness product market investment. Women’s healthcare is a massive profit center before it is a person-centered market. The industry is a key player in the U.S. economy, and one that major corporations will continue to leverage at the expense of patient care. In their pursuit of profit, these corporations, such as Goop, Olly and Ro, have created a scheme out of our healthcare needs — and most of us will inevitably continue playing into it because, as intended by such a system, we have no better option. 

Furthermore, because of the patriarchy’s ongoing influence, the markets for beauty and health bleed into each other, prompting an ongoing emphasis on external appearance and aesthetics in the women’s health industry. Corporations must not continue to perpetuate the idea that an individual’s ability to conform to beauty standards is a marker of health. 

At the same time, research — much of which is currently focused on reproduction-related conditions — must devote attention to overall cardiology, neurology, hormonal work-ups and the different ways that certain health conditions can manifest in women versus men. 

In contrast to the massive size of the women’s health market, only $5 billion per year (roughly 10% of the National Institutes of Health’s annual budget) goes toward women’s health research — all while women increasingly rely on social media and the internet to address their health concerns. Women across our nation are being forced to blindly take their care into their own hands because the current systems we have in place are severely lacking. 

Our multi-trillion-dollar economy should be ashamed of the fact that in an era of flying cars and AI, many women’s healthcare treatments, medications and procedures remain dismissive, dehumanizing and remarkably out of date. The metal speculum serves as a well-known and fitting example — the medical field will continue to use an instrument on women that causes immense pain and psychological stress rather than redirecting funding toward improving patient comfort. IUD insertion and removal procedures often fall short in a similar manner — thousands of women across the nation want or need IUDs, but, in turn, must face the reality that these procedures cause up to 64% of women to experience “extreme pain.” 

Women should not have to consistently face decisions where they cannot win no matter which direction they move in. We must pressure major corporations and politicians who retain influence over major corporations and billionaires to redirect funding toward adequate research, redesign products with patient comfort and experience as a priority, and publicize and close the accessibility gap. 

The democratic socialist Medicare for All initiative reflects a noteworthy stride toward placing government regulation on the consumerist-overtaken monster that is our healthcare system. However, while this movement holds significant virtue, its initiatives are incomplete when examining the quality of care women versus men would receive under such a reform. The Medicare for All initiative must make bridging the gap between women’s and men’s healthcare a clear research priority if it wants a chance to carry out its mission adequately. 

Our nation is in a position to extend the lives of women across the nation, and instead, we consistently waste this potential on designing more half-effective products and conducting pointless studies — such as those centering around how menopause affects male partners. Women attempting to mobilize via social media platforms and educate their counterparts are a stride in the right direction towards building a collective movement to disrupt women’s healthcare as we know it. To prevent more women from feeling helpless within this system, we have a responsibility to create and share trustworthy information. 

We should not have to turn to the internet because the care we receive from doctors does not suffice. We should not have to wait for pain to become life-threatening before we treat it adequately. We should not have to drop thousands of dollars on ineffective hospital treatments and at-home remedies because we have no better resources available. Our nation is out of legitimate excuses — and we cannot let such atrocities persist because, as I’ve consistently learned, this system will leverage our sickness even in our most dire times of need. 

Olivia Brinkman Schooler PO ’29 recently picked up sketching with the hope of recreating moments from the Phoebe Bridgers concert. 

Facebook Comments

Facebook Comments